SQLite Web: event_store.db

Update row sig_c9ed80157eab in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-002286.txt","as_of":"2026-04-16T02:08:52.472606+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-002286.txt","company":"United Health Products, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-002286.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_02ec086a39e6825d","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-002286.txt","content_type":"text/plain","enriched_at":"2026-04-16T02:25:25.979349+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"ueec_10k.htm","final_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-002286.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-002286.txt","source_event_id":"evt_a2ba6ae3df01","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"10-K","fp":"3cdd1141fff7cc9c","kind":"sec_filing","published_at":"20260415","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-16","2026-04-15","2026-04-14","2025-06-30","2025-12-31","2024-03","2024-06"],"entities":[{"asset_class":"equity","name":"United Health Products, Inc.","relevance":"high","symbol":"UEEC","type":"issuer"},{"asset_class":"regulator","name":"U.S. Securities and Exchange Commission (SEC)","relevance":"medium","symbol":"","type":"regulator"},{"asset_class":"regulator","name":"U.S. Food and Drug Administration (FDA)","relevance":"medium","symbol":"","type":"regulator"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal (no prior filing state/delta content included).","The filing\u2019s \u201citem_hints\u201d and \u201cmaterial_items\u201d are empty, and the provided text is partial/truncated (e.g., market value field appears incomplete; additional PMA details after the Deficiencies Letter are cut off).","The filing\u2019s exact SEC file number, registrant telephone number, and the number of shares issued and outstanding are not fully captured in the provided text."],"key_facts":["The document is an Annual Report on Form 10-K for the year ended December 31, 2025.","The filing states the company develops, manufactures, and markets a patented hemostatic gauze (CelluSTAT\u00ae) for healthcare and wound care sectors.","The filing states the company is seeking regulatory approval to sell its hemostatic gauze product line into U.S. Class III and European CE Mark human surgical markets.","The filing states it is continuing its path to seek FDA Premarket Approval (PMA) for CelluSTAT Hemostatic Gauze products.","The filing states that in March 2024, the company submitted a full PMA application to the FDA.","The filing states that in June 2024, the FDA responded with a \u201cDeficiencies Letter\u201d listing approximately 40 specific comments and requests for additional information (text truncated after this point)."],"numeric_claims":[{"label":"Shares held by non-affiliates (as of June 30, 2025)","value":"257,333,222"},{"label":"Market value basis (as of June 30, 2025)","value":"$0.098 per share"},{"label":"Deficiencies Letter comments","value":"approximately 40"}],"primary_claim":"UEEC filed a Form 10-K for the fiscal year ended December 31, 2025.","relevance_score":0.72,"sentiment":"neutral","source_quality":"high","summary":"United Health Products, Inc. (UEEC) filed an Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The filing reiterates its business and ongoing FDA Premarket Approval (PMA) efforts for its CelluSTAT hemostatic gauze products.","topics":["SEC filing","Form 10-K","FDA PMA","CelluSTAT hemostatic gauze","regulatory approval"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 10-K \u00b7 United Health Products, Inc. \u00b7 Filed 20260415","ticker":"UEEC","tickers":["UEEC"],"title":"UEEC filed 10-K","url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-002286.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel